NCT03772340Phase 2Completed

Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2019-06-06Actual

Enrollment · participants126Actual

Source updated2025-05-09Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Study details

Conditions studied

Motion Sickness

Treatments or interventions studied

TradipitantDrug
PlaceboDrug

Primary outcomes · main study measures

Read the study measures

measure: The Most Severe Motion Sickness Severity During Vehicle Travel; description: As measured by the Motion Sickness Severity Scale (MSSS) (NRS 0-6); Lower score indicates improvement; timeFrame: 1 day; measure: Percentage of Vomiting; description: Defined as subjects ever vomited (MSSS=6) or terminated early due to severity during the vehicle travel. As measured by the Motion Sickness Severity Scale (NRS 0-6).; timeFrame: 1 day

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history